These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32294598)

  • 1. PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells.
    Ghalali A; Ye ZW; Högberg J; Stenius U
    Biomed Pharmacother; 2020 Jul; 127():110112. PubMed ID: 32294598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells.
    Ghalali A; Ye ZW; Högberg J; Stenius U
    J Biol Chem; 2014 Apr; 289(17):11601-11616. PubMed ID: 24599953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
    Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
    J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
    Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
    Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PTEN gene silencing on invasion and EMT in oral squamous carcinoma Tca8113 cells.
    Lu Z; Guo H; Lin Y; Shen L; Yin C; Xie S
    J Oral Pathol Med; 2017 Jan; 46(1):31-38. PubMed ID: 27591748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct regulation of transforming growth factor β-induced epithelial-mesenchymal transition by the protein phosphatase activity of unphosphorylated PTEN in lung cancer cells.
    Kusunose M; Hashimoto N; Kimura M; Ogata R; Aoyama D; Sakamoto K; Miyazaki S; Ando A; Omote N; Imaizumi K; Kawabe T; Hasegawa Y
    Cancer Sci; 2015 Dec; 106(12):1693-704. PubMed ID: 26450531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crosstalk between p38 and Akt signaling pathways orchestrates EMT by regulating SATB2 expression in NSCLC cells.
    Kucuksayan H; Akca H
    Tumour Biol; 2017 Sep; 39(9):1010428317706212. PubMed ID: 28937318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.
    Nilchian A; Johansson J; Ghalali A; Asanin ST; Santiago A; Rosencrantz O; Sollerbrant K; Vincent CT; Sund M; Stenius U; Fuxe J
    Cancer Res; 2019 Jan; 79(1):47-60. PubMed ID: 30385615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
    Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
    Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression.
    Chen M; Pratt CP; Zeeman ME; Schultz N; Taylor BS; O'Neill A; Castillo-Martin M; Nowak DG; Naguib A; Grace DM; Murn J; Navin N; Atwal GS; Sander C; Gerald WL; Cordon-Cardo C; Newton AC; Carver BS; Trotman LC
    Cancer Cell; 2011 Aug; 20(2):173-86. PubMed ID: 21840483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1 Induces Epithelial-Mesenchymal Transition of Chronic Sinusitis with Nasal Polyps through MicroRNA-21.
    Li X; Li C; Zhu G; Yuan W; Xiao ZA
    Int Arch Allergy Immunol; 2019; 179(4):304-319. PubMed ID: 30982052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway.
    Liu Z; Wang J; Guo C; Fan X
    Biomed Pharmacother; 2015 Feb; 69():24-8. PubMed ID: 25661333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
    Kimbrough-Allah MN; Millena AC; Khan SA
    Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.
    Mulholland DJ; Tran LM; Li Y; Cai H; Morim A; Wang S; Plaisier S; Garraway IP; Huang J; Graeber TG; Wu H
    Cancer Cell; 2011 Jun; 19(6):792-804. PubMed ID: 21620777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer.
    Kim RJ; Bae E; Hong YK; Hong JY; Kim NK; Ahn HJ; Oh JJ; Park DS
    Oncology; 2014; 87(5):270-9. PubMed ID: 25139413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
    Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
    Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.